GO
Loading...

Bristol-Myers Executive Charged With Insider Trading

FBI agents arrested Robert Ramnarine, a Bristol-Myers Squibbexecutive, on Thursday. He has been criminally charged with insider trading the call options of companies shortly before they were acquired, court papers show.

CNBC.com

Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, N.J., was arrested by agents at a suburban New Jersey home this morning.

A three-count criminal complaint was unsealed this morning. According the complaint, he made more than $311,000 in illegal profit.

The insider trading in question involved several stocks, including ZymoGenetics, Pharmasset and Amylin Pharmaceuticals.

Ramnarine will have his initial court appearance later this afternoon. It is unclear whether Ramnarine has hired a lawyer for his defense.

In his position at Bristol-Myers Squibb, he was responsible for conducting due diligence concerning the pension plans of the company's acquisition targets.

No immediate response from Bristol-Myers Squibb was available.

— By CNBC's Jim Forkin. Reuters contributed to this article.

Symbol
Price
 
Change
%Change
BMY
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Artillery fire has slammed into a huge oil depot near the airport in Libya; and a massive explosion occurred at the main hospital in Gaza where Hamas leaders are reportedly hiding. CNBC's Tyler Mathisen provides insight to the crisis in the Middle East, as well as in Ukraine.

  • CNBC's Steve Liesman reports expectations from the Fed's monetary policy announcement and economic outlook.

  • CNBC's Bob Pisani reports Q2 revenues are getting better as the earnings parade continues, and what's to come for the rest of the trading day.